CAR-T cell therapy: Industries
Industries
The industries and kinds of firm that use or make it, how far they have taken it up and what it does to them
Made by- Innovator pharma and biotech companies New class of personalised medicine Novartis makes Kymriah for each patient at its Morris Plains plant [3]; seven products from several firms are approved in the US [1].
- Hospitals and specialty hospital chains Specialist cancer treatment Hospitals collect the patient's blood, give the infusion and manage side effects such as cytokine release syndrome [1]; Penn and the Children's Hospital of Philadelphia ran the first trials [4].
as of 2026-11-11
Sources
- CAR T Cells: Engineering Patients' Immune Cells to Treat Their Cancers National Cancer Institute (NIH), 2025
- FDA Approves Novartis' CAR-T Drug, First Gene Therapy Approval in US Pharmaceutical Technology, 2017
- FDA Approves Personalized Cellular Therapy for Advanced Leukemia (news release) Penn Medicine, 2017